AnalystsRudy LiRudy Li's Stock Forecasts
AnalystsRudy Li
Sectors:
Industries:
Analyst Ranking
Top 20%
#967 out of 4995 analysts
Average Return
+22.97%
Win Rate
73%16 out of 22
Risk vs Reward
Poor
Good
Rudy Li's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Stoke Therapeutics IncSTOK | +136.80% | $8.26 | $19.56 | 2025-03-19 - 2025-08-22 | Strong Buy |
Stoke Therapeutics IncSTOK | +110.32% | $9.30 | $19.56 | 2025-02-19 - 2025-08-22 | Strong Buy |
Prothena Corp Public Ltd CoPRTA | +91.48% | $4.58 | $8.77 | 2025-05-27 - 2025-08-22 | Strong Buy |
Stoke Therapeutics IncSTOK | +67.47% | $11.68 | $19.56 | 2024-12-20 - 2025-08-22 | Strong Buy |
Mind Medicine IncMNMD | +65.69% | $6.15 | $10.19 | 2025-05-09 - 2025-08-22 | Strong Buy |
Rudy Li Analyst Color
Get additional color on Rudy Li's coverage of popular stocks
Rudy Li's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $24.00 | +22.70% | Maintains | 12 days ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $55.00 | +41.61% | Maintains | 13 days ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $30.00 | +76.37% | Maintains | 13 days ago |
Prothena Corp Public Ltd CoPRTA | 6 | Strong Buy | $18.00 | +105.25% | Maintains | 21 days ago |
Mind Medicine IncMNMD | 4 | Strong Buy | $20.00 | +96.27% | Maintains | 25 days ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $80.00 | +64.00% | Maintains | a month ago |
Bright Minds Biosciences IncDRUG | 2 | Strong Buy | $80.00 | N/A | Maintains | 3 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.